MolNFT v1 · #9202 · protein
Inhibition of human immunodeficiency virus-1 protease by a C2- symmetric phosphinate synthesis and crystallographic analysis
1HOS · HIV-1 protease: “Inhibition of human immunodeficiency virus-1 protease by a C2- symmetric phosphinate synthesis and…”. X-ray diffraction, 1 ligand (PHP), 1 pocket (best druggability 0.69). MolNFT v1 #9202 on GenesisL1: 3D structure…
- PDB
- 1HOS
- Type
- protein
- Length
- 198 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- HIV-1 protease
- UniProt
- P03366
- Ligands
- PHP
- Pockets
- 1 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 4% helix, 54% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | HIV-1 protease | protein | 99 | 4% helix, 54% strand | P03366 |
Ligands and binding sites
- PHP · (2-phenyl-1-carbobenzyl-oxyvalyl-amino)-ethyl-phosphinic acid · ligand · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 399 | 0.69 | 0.81 | 41 | PHP |
Interfaces
1 interface between chains.
- A–B · 1811 Ų buried · 37 hydrogen bonds · protein-protein
Compared structures
- 1HOS · Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P03366
- Elsewhere: RCSB PDB 1HOS · PDBe 1HOS · UniProt P03366
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.